top | item 42445158

(no title)

jessfyi | 1 year ago

The cases of NAION observed post-Ozempic usage in Denmark is 150 (up from 60-75) out of 424,152 patients, for a rare ailment that already affects patients specifically with diabetes. Sorry to say those taking it as a "shortcut" in your words are even less susceptible.

As someone who's been fortunate enough to be fit and able to work out their entire life, not sure how there are people like you who shun and shame those trying to gain a semblance of control over their weight in a world where it does have a real impact whether they get serious medical attention or not. Your likely skewed thoughts on vanity be damned, bigger people are treated worse across the board and GLP-1 is a genuine salve.

discuss

order

No comments yet.